---
title: "Adial Pharmaceuticals surges 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303254521.md"
description: "Adial Pharmaceuticals rose 8.15% to US$3.980. Up 146.15% over six months and down 30.18% YTD."
datetime: "2026-10-27T15:01:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303254521.md)
  - [en](https://longbridge.com/en/news/303254521.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303254521.md)
generator: "portal-rs"
---

# Adial Pharmaceuticals surges 8%

Adial Pharmaceuticals (ADIL.US) surged more than **8%** during regular trading to **$3.98**.

The stock is up 16.72% over the past ten sessions, up 146.15% over the past six months and down 30.18% year to date. It sits 203.82% above its 52-week low of US$1.310. Volume was 0.17 times its average.

The Nasdaq Composite is little changed over the past five sessions and up 13.66% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [AZR.US](https://longbridge.com/en/quote/AZR.US.md)

## Related News & Research

- [Adial Pharmaceuticals delays shareholder meeting vote on proposals 3-6 to Oct. 15 pending Nasdaq approval](https://longbridge.com/en/news/300824661.md)
- [Adial Pharmaceuticals Files Initial Beneficial Ownership Statement for CFO Vassiliki Economides](https://longbridge.com/en/news/303813186.md)
- [Is ServiceNow (NOW) Trading At Too High A Premium For Earnings?](https://longbridge.com/en/news/306039339.md)
- [Alibaba Q2 revenue rises on AI Cloud and Compute Services strength](https://longbridge.com/en/news/306100634.md)
- [Lenovo Group: Record sales and adjusted profit growth were offset in reported results by warrant revaluation losses](https://longbridge.com/en/news/306059225.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**